兄弟科技(002562) - 2024 Q4 - 年度业绩

Financial Performance - Total revenue for 2024 reached CNY 3,441,405,206.38, representing a year-on-year increase of 21.99%[4] - Operating profit was CNY 52,128,495.19, a significant turnaround from a loss of CNY 154,384,396.97 in the previous year, marking a growth of 133.77%[4] - Net profit attributable to shareholders was CNY 39,816,742.45, compared to a loss of CNY 175,468,814.06 last year, reflecting an increase of 122.69%[4] - The basic earnings per share improved to CNY 0.04 from a loss of CNY 0.17, representing a growth of 123.53%[4] - The weighted average return on net assets was 1.29%, recovering from -5.48% in the previous year[4] Assets and Equity - The company's total assets at the end of the reporting period were CNY 5,871,268,545.38, a slight decrease of 0.26% year-on-year[5] - Shareholders' equity increased by 1.46% to CNY 3,098,704,322.83 compared to the beginning of the period[5] Revenue Drivers - The increase in revenue and profit was attributed to rising prices of certain vitamin products and improved production capacity[5] Reporting and Forecasts - The company confirmed that there were no discrepancies between the reported results and previous earnings forecasts[6] - Detailed financial data will be disclosed in the 2024 annual report[7]